Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Nov;36(11):823–828.

A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD)

S M van der Maarel 1, G Deidda 1, R Lemmers 1, E Bakker 1, M J R van der Wielen 1, L Sandkuijl 1, J Hewitt 1, G Padberg 1, R Frants 1
PMCID: PMC1734251  PMID: 10544225

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the size reduction of a polymorphic repeat array on 4q35. Probe p13E-11 recognises this chromosomal rearrangement and is generally used for diagnosis. However, diagnosis of FSHD is complicated by three factors. First, the probe cross hybridises to a highly homologous repeat array locus on chromosome 10q26. Second, although a BlnI polymorphism allows discrimination between the repeat units on chromosomes 4 and 10 and greatly facilitates FSHD diagnosis, the occurrence of translocations between chromosomes 4 and 10 further complicates accurate FSHD diagnosis. Third, the recent identification of deletions of p13E-11 in both control and FSHD populations is an additional complicating factor. Although pulsed field gel electrophoresis is very useful and sometimes necessary to detect these rearrangements, this technique is not operational in most FSHD diagnostic laboratories. Moreover, repeat arrays >200 kb are often difficult to detect and can falsely suggest a deletion of p13E-11. Therefore, we have developed an easy and reliable Southern blotting method to identify exchanges between 4 type and 10 type repeat arrays and deletions of p13E-11. This BglII-BlnI dosage test addresses all the above mentioned complicating factors and can be carried out in addition to the standard Southern blot analysis for FSHD diagnosis as performed in most laboratories. It will enhance the specificity and sensitivity of conventional FSHD diagnosis to the values obtained by PFGE based diagnosis of FSHD. Moreover, this study delimits the FSHD candidate gene region by mapping the 4;10 translocation breakpoint proximal to the polymorphic BlnI site in the first repeat unit.


Keywords: FSHD; diagnosis; dosage; subtelomere

Full Text

The Full Text of this article is available as a PDF (141.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker E., Van der Wielen M. J., Voorhoeve E., Ippel P. F., Padberg G. W., Frants R. R., Wijmenga C. Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases. J Med Genet. 1996 Jan;33(1):29–35. doi: 10.1136/jmg.33.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakker E., Wijmenga C., Vossen R. H., Padberg G. W., Hewitt J., van der Wielen M., Rasmussen K., Frants R. R. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve Suppl. 1995;2:S39–S44. [PubMed] [Google Scholar]
  3. Cacurri S., Piazzo N., Deidda G., Vigneti E., Galluzzi G., Colantoni L., Merico B., Ricci E., Felicetti L. Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy. Am J Hum Genet. 1998 Jul;63(1):181–190. doi: 10.1086/301906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deidda G., Cacurri S., Grisanti P., Vigneti E., Piazzo N., Felicetti L. Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet. 1995;3(3):155–167. doi: 10.1159/000472291. [DOI] [PubMed] [Google Scholar]
  5. Deidda G., Cacurri S., Piazzo N., Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet. 1996 May;33(5):361–365. doi: 10.1136/jmg.33.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lemmers R. J., van der Maarel S. M., van Deutekom J. C., van der Wielen M. J., Deidda G., Dauwerse H. G., Hewitt J., Hofker M., Bakker E., Padberg G. W. Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet. 1998 Aug;7(8):1207–1214. doi: 10.1093/hmg/7.8.1207. [DOI] [PubMed] [Google Scholar]
  7. Lunt P. W. 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19-21 July 1996, Naarden, The Netherlands. Neuromuscul Disord. 1998 Apr;8(2):126–130. doi: 10.1016/s0960-8966(98)00012-1. [DOI] [PubMed] [Google Scholar]
  8. Smith K. N., Nicolas A. Recombination at work for meiosis. Curr Opin Genet Dev. 1998 Apr;8(2):200–211. doi: 10.1016/s0959-437x(98)80142-1. [DOI] [PubMed] [Google Scholar]
  9. Wijmenga C., Frants R. R., Brouwer O. F., Moerer P., Weber J. L., Padberg G. W. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990 Sep 15;336(8716):651–653. doi: 10.1016/0140-6736(90)92148-b. [DOI] [PubMed] [Google Scholar]
  10. Wijmenga C., Hewitt J. E., Sandkuijl L. A., Clark L. N., Wright T. J., Dauwerse H. G., Gruter A. M., Hofker M. H., Moerer P., Williamson R. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992 Sep;2(1):26–30. doi: 10.1038/ng0992-26. [DOI] [PubMed] [Google Scholar]
  11. van Deutekom J. C., Bakker E., Lemmers R. J., van der Wielen M. J., Bik E., Hofker M. H., Padberg G. W., Frants R. R. Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet. 1996 Dec;5(12):1997–2003. doi: 10.1093/hmg/5.12.1997. [DOI] [PubMed] [Google Scholar]
  12. van Deutekom J. C., Wijmenga C., van Tienhoven E. A., Gruter A. M., Hewitt J. E., Padberg G. W., van Ommen G. J., Hofker M. H., Frants R. R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993 Dec;2(12):2037–2042. doi: 10.1093/hmg/2.12.2037. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES